Clinical trials
Completed Phase 2 Acromegaly trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ionis Pharmaceuticals, Inc. | 3 |
| Novartis Pharmaceuticals | 3 |
| Aspireo Pharmaceuticals Limited | 2 |
| Crinetics Pharmaceuticals Inc. | 2 |
| Andrea M. Isidori | 1 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 1 |
| Camurus AB | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
| Felipe Henning Gaia Duarte | 1 |
| Italfarmaco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acromegaly | 17 |
| Pituitary Neoplasms | 2 |
| Gigantism | 1 |
| Growth Disorders | 1 |
| Hypertrophy, Left Ventricular | 1 |
| Neuroendocrine Tumors | 1 |
| Serotonin Syndrome | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.